Gene Therapy Milestone: An infant with ultra-rare WOREE syndrome became the first patient worldwide to receive experimental WWOX gene replacement therapy in the brain at Schneider Children’s Medical Center of Israel, marking a major step for precision treatments in rare neurological disease. Cancer & Cell Therapy Push: Imugene’s off-the-shelf CAR T azer-cel won FDA Fast Track for relapsed/refractory CLL/SLL and marginal zone lymphoma, aiming to cut the manufacturing delays that can hurt patients with aggressive disease. Public Health Trust: A new U.S. poll finds only half of Americans trust CDC public health recommendations now, down sharply from last year—raising alarms about polarization around health guidance. Maternal Care Recognition: Five Geisinger hospitals received awards for maternal and newborn care improvements, including work on maternal sepsis. Medicaid Oversight: North Dakota announced a new Medicaid strategy starting July 1 to strengthen provider revalidation and prevent fraud, targeting high-risk provider categories. Healthcare Workforce Tension: Romania’s healthcare and sanitation workers launched a warning strike over a public-sector pay bill that could cap or cut salaries for many employees. Access & Equity: Tennessee plans to verify immigration status for Children’s Special Services, putting some low-income immigrant children’s life-sustaining coverage at risk. Drug Safety Warning: The EU drug agency warns of dangerous synthetic opioids in fake medicines, with overdose deaths at record levels. Clinical Research in Pregnancy: LSU Health Shreveport is enrolling women in the REBIRTH trial testing bromocriptine for peripartum cardiomyopathy, a leading cause of death after childbirth.